El Salvador vs Kyrgyzstan: Cause of death, by non-communicable diseases, ages 5-14
Cause of death, by non-communicable diseases, ages 5-14 over time
- El Salvador
- Kyrgyzstan
How they compare
Kyrgyzstan currently reports 36.0% against 34.1% in El Salvador, a difference of 1.9%.
That makes Kyrgyzstan's figure about 1.1 times El Salvador's.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was El Salvador ahead.
El Salvador ranks 102nd and Kyrgyzstan ranks 100th of 185 countries.
Across the 3 decades both report, El Salvador averaged higher in 2 and Kyrgyzstan in 1.
Head to head by decade
| Decade | El Salvador | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.0% | 28.5% | 1.5% | El Salvador |
| 2010s | 35.8% | 35.7% | 0.1% | El Salvador |
| 2020s | 34.3% | 36.1% | 1.8% | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, El Salvador or Kyrgyzstan?
- Kyrgyzstan, at 36.0% against 34.1% in El Salvador as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between El Salvador and Kyrgyzstan?
- 1.9%, with Kyrgyzstan ahead.
- How many years of comparable data are there for El Salvador and Kyrgyzstan?
- 6 years are reported by both, from 2000 to 2021.
- How do El Salvador and Kyrgyzstan rank globally for cause of death, by non-communicable diseases, ages 5-14?
- El Salvador ranks 102nd and Kyrgyzstan ranks 100th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.